Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05972889 · ClinicalTrials.gov registry record · NA
Randomized Blinded Evaluation of the Effects of TENS and IFC Compared to a Sham Device and SOC in Patients With Non-Specific CLBP
A NA study of Non-Specific Chronic Lower Back Pain, sponsored by Zynex Medical.
- Completed
- Registry status
- NA
- Development phase
- 334
- Enrollment target
- 8
- Study locations
NCT05972889 is a NA study of Non-Specific Chronic Lower Back Pain that has completed, run by Zynex Medical. The registered enrollment target is 334 participants. The trial reports 8 study locations across 7 states.
The verdict
NCT05972889, a NA study of Non-Specific Chronic Lower Back Pain, has completed, sponsored by Zynex Medical.
- COMPLETED
- Registry status
- NA
- Development phase
- 334 participants
- Enrollment target
- 8
- Study locations
Study Summary
This is a prospective, sham-controlled, randomized, single-blinded, multi-center study comparing two different modes of the NexWave device, transcutaneous electrical nerve stimulation (TENS) and interferential current (IFC), with an identical non-functioning NexWave sham device or self-defined standard of care for improvement of pain intensity of non-specific CLBP.
Conditions Studied
Interventions
- DEVICE Sham
- DEVICE NexWave
Study Locations (8)
Georgia
- Peachtree Orthopedics - Atlanta
- Horizon Clinical Research - Jasper
Colorado
- DBPS Research - Greenwood Village
Florida
- McGreevy NeuroHealth - Saint Augustine
Illinois
- Applied Pain Institute, LLC - Bloomington
New York
- One Oak Medical - Congers
North Carolina
- The Center for Clinical Research, LLC - Winston-Salem
Utah
- Summit Brain, Spine and Orthopedics - Lehi
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 334 participants |
| Start Date | 2023-11-02 |
| Est. Completion | 2025-10-21 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05972889
The ClinicalTrials.gov registry entry for NCT05972889 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 334 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Zynex Medical, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Non-Specific Chronic Lower Back Pain appearing as the primary indexed condition, and to 2 interventions - of which Sham is the first listed.
NCT05972889 reports 8 study locations spanning 7 distinct geographic areas - top geographies include Georgia, Colorado, Florida.
Frequently Asked Questions
What is clinical trial NCT05972889 about?
NCT05972889 is a clinical study titled "Randomized Blinded Evaluation of the Effects of TENS and IFC Compared to a Sham Device and SOC in Patients With Non-Specific CLBP". This is a prospective, sham-controlled, randomized, single-blinded, multi-center study comparing two different modes of the NexWave device, transcutaneous electrical nerve stimulation (TENS) and interferential current (IFC), with an identical non-functioning NexWave sham device or self-defined stand...
What is the current status of trial NCT05972889?
This trial is currently completed. It is a NA study. The enrollment target is 334 participants. The study started on 2023-11-02. Estimated completion is 2025-10-21.
What conditions does trial NCT05972889 study?
This clinical trial studies the following conditions: Non-Specific Chronic Lower Back Pain.
What interventions are being tested in trial NCT05972889?
The interventions under investigation include: Sham (DEVICE), NexWave (DEVICE).
Who is sponsoring clinical trial NCT05972889?
This trial is sponsored by Zynex Medical, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05972889 being conducted?
This trial has 8 study locations across Colorado, Florida, Georgia, Illinois, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.